GREENWOOD VILLAGE, Colo. & NEW HAVEN, Conn.–(BUSINESS WIRE)– #OUD–ANANDA Scientific Inc., a research-focused biopharmaceutical company, today announced the commencement of a clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol (CBD), leveraging ANANDA’s proprietary delivery technology, co-administered with delta-9-tetrahydrocannabinol (THC), for its potential efficacy in treating co-occurring opioid use disorder (OUD) and chronic pain. (Clinical Trials.gov Identifier:
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
